» Articles » PMID: 26743151

Clinical Implications of 5 Cases of Middle East Respiratory Syndrome Coronavirus Infection in a South Korean Outbreak

Overview
Date 2016 Jan 9
PMID 26743151
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The Korea Middle East respiratory syndrome coronavirus (MERS-CoV) was first confirmed on May 20, 2015, with a subsequent outbreak in South Korea. Five patients with suspected MERS-CoA infection were admitted to our hospital during this outbreak. One patient had no major symptoms upon admission, but pneumonia was identified upon chest radiography. Two patients progressed rapidly to acute respiratory failure and required ventilator-assisted respiration. One patient required extracorporeal membrane oxygenation to treat refractory hypoxemia, and one patient died of shock with multiorgan failure. All the patients had fever, myalgia, leucopenia, normal procalcitonin level, and pneumonia. Importantly, clinicians should test for pneumonia in all suspected patients with MERS-CoV infection, even in the absence of respiratory symptoms. The pneumonia usually affected the lower lobes. A shorter incubation period was associated with more severe disease and greater risk of mortality, and the severity of fever predicted the prognosis of MERS-CoV infection-related pneumonia. Therefore, in cases of lower-lobe pneumonia that occur during an MERS-CoV outbreak and are unesponsive to antibiotics, clinicians should consider the possibility of MERS-CoV infection.

Citing Articles

Deep Learning for Reliable Classification of COVID-19, MERS, and SARS from Chest X-ray Images.

Tahir A, Qiblawey Y, Khandakar A, Rahman T, Khurshid U, Musharavati F Cognit Comput. 2022; 14(5):1752-1772.

PMID: 35035591 PMC: 8747861. DOI: 10.1007/s12559-021-09955-1.


Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Saleki K, Yaribash S, Banazadeh M, Hajihosseinlou E, Gouravani M, Saghazadeh A Eur J Pharmacol. 2021; 906:174248.

PMID: 34126092 PMC: 8195694. DOI: 10.1016/j.ejphar.2021.174248.


Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19.

Jozwiak M, Chiche J, Charpentier J, AIt Hamou Z, Jaubert P, Benghanem S Front Med (Lausanne). 2020; 7:614569.

PMID: 33363190 PMC: 7758460. DOI: 10.3389/fmed.2020.614569.


Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).

Ma X, Liang M, Ding M, Liu W, Ma H, Zhou X Med Sci Monit. 2020; 26:e925364.

PMID: 32759887 PMC: 7430351. DOI: 10.12659/MSM.925364.


ECMO use in COVID-19: lessons from past respiratory virus outbreaks-a narrative review.

Cho H, Heinsar S, Jeong I, Shekar K, Li Bassi G, Jung J Crit Care. 2020; 24(1):301.

PMID: 32505217 PMC: 7275850. DOI: 10.1186/s13054-020-02979-3.